Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism (2010)

  • Authors:
  • USP affiliated authors: MUSCARA, MARCELO NICOLAS - ICB
  • USP Schools: ICB
  • DOI: 10.1007/s00280-009-1031-8
  • Subjects: FARMACOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00280-009-1031-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Cancer Chemotherapy and Pharmacology

    ISSN: 0344-5704

    Citescore - 2017: 2.91

    SJR - 2017: 1.147

    SNIP - 2017: 0.899


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100025037PC-ICB BMF SEP 2010
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BASTOS-PEREIRA, Amanda Leite; LUGARINI, Daiana; OLIVEIRA-CHRISTOFF, Adriana de; et al. Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemotherapy and Pharmacology, Berlin, v. 65, n. 2, p. 267-76, 2010. DOI: 10.1007/s00280-009-1031-8.
    • APA

      Bastos-Pereira, A. L., Lugarini, D., Oliveira-Christoff, A. de, Ávila, T. V., Teixeira, S., Pires, A. do R. A., et al. (2010). Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemotherapy and Pharmacology, 65( 2), 267-76. doi:10.1007/s00280-009-1031-8
    • NLM

      Bastos-Pereira AL, Lugarini D, Oliveira-Christoff A de, Ávila TV, Teixeira S, Pires A do RA, Muscará MN, Cadena SMSC, Donatti L, da Silva de Assis HC da, Acco A. Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemotherapy and Pharmacology. 2010 ; 65( 2): 267-76.
    • Vancouver

      Bastos-Pereira AL, Lugarini D, Oliveira-Christoff A de, Ávila TV, Teixeira S, Pires A do RA, Muscará MN, Cadena SMSC, Donatti L, da Silva de Assis HC da, Acco A. Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemotherapy and Pharmacology. 2010 ; 65( 2): 267-76.

    Referências citadas na obra
    Gasparini G, Longo R, Sarmiento R, Morabito A (2003) Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 4:605–615
    Grösh S, Maier TJ, Schiffmann S, Geisslinger G (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 98(11):736–747
    Reddy BS, Hirose Y, Lubet R, Steele V, Kelloff G, Paulson S, Seibert K, Rao CV (2000) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, Celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293–297
    Amir M, Agarwal HK (2005) Role of COX-2 selective inhibitors for prevention and treatment of cancer. Pharmazie 60(8):563–570
    Cianchi F, Cortesini C, Fantappiè O, Messerini L, Sardi I, Lasagna N, Perna F, Fabbroni V, Di Felice A, Perigli G, Mazzanti R, Masini E (2004) Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer. Clin Cancer Res 10:2694–2704
    Kirkova M, Alexandova A, Kesiova M, Todorov S (2007) In vivo effects of amtolmetin guacyl on lipid peroxidation and antioxidant defense systems Comparison with non-selective and COX-2 selective NSAIDs. Auton Autacoid Pharmacol 27(2):99–104
    Lev N, Melamed E, Offen D (2003) Apoptosis and Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 27:245–250
    Guaitani A, Recchia M, Carli M, Rocchetti M, Bartosek I, Garattini S (1982) Walker carcinoma 256: a model for studies on tumor-induced anorexia and cachexia. Oncology 39:173–178
    Vicentino C, Constan TINJ, Bracht A, Yamamoto NS (2002) Long-chain fatty acid uptake and oxidation in the perfused liver of Walker-256 tumour-bearing rats. Liver 22:342–350
    Mizuno M, Minato K, Ito H, Kawade M, Terai H, Tsuchida H (1999) Anti-tumor polysaccharide from the mycelium of liquid cultured Agaricus blazei mill. Biochem Mol Biol Int 47:707–714
    Voss DO, Campelo AP, Bacila M (1961) The respiratory chain and the oxidative phosphorylation of rat brain mitochondria. Biochem Biophys Res Commun 4(1):48–51
    Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254
    Chen Y, Wang M, Rosen RT, Ho CT (1999) 1.1-Diphenyl-2-picrylhydrazyl radical-scavenging active components from Polygonum multiflorum thunb. J Agric Food Chem 47:2226–2228
    Aebi H (1984) Catalase in vitro. Academic Press 105:121–126
    Gao R, Yuan Z, Zhao Z, Gao X (1998) Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activity. Bioelectrochem Bioenerg 45:41–45
    Habig WH, Papst MJ, Jakoby WB (1974) Glutathione S-transferases: the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139
    Jiang Y, Woollard ACS, Wolff SP (1991) Lipid hydroperoxide measurement by oxidation of Fe+2 in the presence of iilenol orange—Comparison with the TBA assay and an iodometric method. Lipids 26:853–856
    Singer TP (1974) Determination of the activity of succinate, NADH, choline and α-glycerophosphate dehydrogenases. Methods Biochem Anal 22:123–175
    Estabrook RW (1967) Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Method Enzymol 10:41–47
    Sambrook J, Fritish EF, Manniatis T (1989) Molecular cloning: a laboratory manual 15:1847–1876
    Luft JH (1961) Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 9:409–414
    Reybolds ES (1963) The use of lead citrate at high pH as an electron—opaque stain in electron microscopy. J Cellular Biology 17:208–212
    Harris RE, Beebe-Donk J, Alshafie GA (2006) Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 30:6–27
    Toth B, Coles M (2006) Inhibition of large intestinal cancers by celecoxib using a serial sacrifice technique. In Vivo 20(4):453–457
    GEE J, Lee IL, Jendiroba D, Fischer SM, Grossman HB, Sabichi AL (2006) Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer. Oncol Rep 15(2):471–477
    Acco A, Alves da Silva MH, Batista MR, Yamamoto NS, Bracht A (2007) Action of celecoxib on the hepatic metabolic changes induced by the Walker-256 tumor in rats. Basic Clin Pharmacol Toxicol 101:294–300
    Homem-de-Bittencourt PI Jr, Pontieri V, Curi R, Lopes OU (1989) Effects of aspirin-like drugs on Walker 256 tumor growth and cachexia in rats. Braz J Med Biol Res 22(8):1039–1042
    Süleyman H, Demircan B, Karagöz A (2007) Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep 59:247–258
    Varani J, Perone P (1985) Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites. J Natl Cancer Inst 74(1):165–172
    Tang DG, Chen YQ, Hon KV (1996) Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Nat Acad Sci – USA 93:5241–5246
    Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P (2005) Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res 7:422–435
    Chan CM, Ma BB, Wong SC, Chan AT (2005) Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. Biomed Pharmacother Suppl 2:S268–S271
    Sauter ER, Schlatter L, Hewett J, Koivunen D, Flynn JT (2004) Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancer. Cancer Epidemiol Biomarkers Prev 13(11):1745–1750
    Rodríguez-Enríquez S, Vital-González PA, Flores-Rodríguez FL, Marín-Hernández A, Ruiz-Azuara L, Moreno-Sánchez R (2006) Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol Appl Pharmacol 215:208–217
    Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E (2007) Energy metabolism in tumor cells. FEBS J 274:1393–1418
    Kemmelmeier FS, Bracht Adelar (1989) Effects of the nonsteroidal anti-inflammatory drug mefenamic acid on energy metabolism in the perfused rat liver. Biochem Pharmacol 38:823–830
    Petruscu I, Tarba C (1997) Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochim Biophys Acta 1318:385–394
    Freitas JJ, Pompéia C, Miyasaka CK, Curi R (2001) Walker-256 tumor growth causes oxidative stress in rat brain. J Neurochem 77:655–663
    Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 60:1–40
    Deweese TL, Hruskewycz AM, Marnett LJ (2001) Oxidative stress in chemoprevention trials. Urol 57:137–140
    Wang D, DuBois RN (2006) Prostaglandins and Cancer Gut 55:115–122